Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

Antimicrob Agents Chemother. 1998 Sep;42(9):2425-6. doi: 10.1128/AAC.42.9.2425.

Abstract

Of a total of 147 erythromycin-resistant Streptococcus pneumoniae isolates, 64 (43.5%) were resistant to erythromycin, clindamycin, and streptogramin B (MLSB phenotype), 57 of which possessed the ermB gene. Eighty-two (55.8%) were resistant to erythromycin alone (M phenotype), 81 of which possessed the mefE gene. One was erythromycin and streptogramin B resistant but susceptible to clindamycin (MS phenotype) and possessed neither the erm gene nor the mefE gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial / genetics
  • Lincosamides
  • Macrolides*
  • Polymerase Chain Reaction
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics
  • Virginiamycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Lincosamides
  • Macrolides
  • Virginiamycin